THE MONKEYPOX VACCINE IS APPROVED FOR ADOLESCENTS IN THE EU

THE MONKEYPOX VACCINE IS APPROVED FOR ADOLESCENTS IN THE EU

.

Saved in:

Bibliographic Details
Main Author:	Article Editorial
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2024-11-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/2534
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE
by: article Editorial
Published: (2025-05-01)

On Approval of the Plan for a Phased Transition to the Use of Quadrivalent Vaccines for the Prevention of Influenza
by: article Editorial
Published: (2019-03-01)

Knowledge of monkeypox and willingness to vaccinate against monkeypox among Chinese college students: A cross-sectional study
by: Linqiong Zhou, et al.
Published: (2025-04-01)

Challenges in Global Distribution and Equitable Access to Monkeypox Vaccines
by: Nengak P. Danladi, et al.
Published: (2024-11-01)

Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines
by: Anna-Lise Williamson
Published: (2025-01-01)

EUROPEAN COMMISSION HAS APPROVED NEW VACCINE TO PROTECT CHILDREN FROM PNEUMOCOCCAL INFECTION
by: article Editorial
Published: (2024-05-01)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023-08-01)

Ministry of Public Health of the Russian Federation has Approved a Vaccine Against Herpes Zoster
by: article Editorial
Published: (2023-11-01)

Advances in monkeypox: exploring vaccines and therapeutic drugs for prevention and treatment
by: Maryam Ajel, et al.
Published: (2024-03-01)

The FDA has approved a vaccine for the prevention of whooping cough in infants up to 2 months of life
by: article Editorial
Published: (2023-01-01)

Media Matters: How Information Release Shapes Monkeypox Vaccination Willingness
by: Huan Wang, et al.
Published: (2024-11-01)

Generalised pustular psoriasis triggered by monkeypox vaccination successfully treated with spesolimab
by: Jose H. Alfonso, et al.
Published: (2024-12-01)

Sculpting multi-epitope vaccine against Monkeypox viral strains using immunoinformatics
by: Zaira Rehman, et al.
Published: (2025-01-01)

APPROVAL OF THE LIST OF MEDICINAL REMEDIES
by: article editorial
Published: (2006-02-01)

Tongue Lesions in Monkeypox
by: Luis Arthur Brasil Gadelha Farias, et al.
Published: (2025-03-01)

Monkeypox - A Review
by: Ijaz Hussain, et al.
Published: (2023-03-01)

Monkeypox - A Review
by: Ijaz Hussain, et al.
Published: (2023-03-01)

Monkeypox : Time for Awareness
by: Natarajan Arvind
Published: (2022-12-01)

Monkeypox: An Ignored Adversary
by: Sadaf Haris
Published: (2022-07-01)

Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination
by: Kara Phipps, et al.
Published: (2025-02-01)

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Topical roflumilast approved for psoriasis treatment
by: article Editorial
Published: (2022-10-01)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

Alopecia and monkeypox: a consideration
by: Pathum Sookaromdee, et al.
Published: (2023-04-01)

Diagnostic approaches for monkeypox virus
by: Guohao Fan, et al.
Published: (2024-03-01)

Monkeypox Virus: A Review
by: Huda Mawlood Taher, et al.
Published: (2025-05-01)

Monkeypox transmission risks in Indonesia
by: Hermawan Saputra, et al.
Published: (2022-09-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma
by: article Editorial
Published: (2023-05-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development
by: Jing Liu, et al.
Published: (2025-02-01)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023-11-01)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024-09-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS
by: article Editorial
Published: (2025-05-01)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024-07-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023-12-01)

Two new indications for pembrolizumab have been approved in Russia
by: article Editorial
Published: (2020-11-01)